ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 62 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $280,037,058 | -28.9% | 13,959,973 | 0.0% | 3.36% | -26.6% |
| Q2 2023 | $393,810,838 | +148.9% | 13,959,973 | +51.7% | 4.58% | +112.9% |
| Q1 2023 | $158,239,536 | -14.6% | 9,199,973 | 0.0% | 2.15% | -39.2% |
| Q4 2022 | $185,287,456 | -7.0% | 9,199,973 | 0.0% | 3.54% | -7.2% |
| Q3 2022 | $199,271,000 | -22.9% | 9,199,973 | 0.0% | 3.81% | -34.9% |
| Q2 2022 | $258,519,000 | +28.8% | 9,199,973 | +111.5% | 5.86% | +143.2% |
| Q1 2022 | $200,676,000 | -45.1% | 4,349,279 | 0.0% | 2.41% | -40.8% |
| Q4 2021 | $365,600,000 | +26.1% | 4,349,279 | 0.0% | 4.07% | +23.4% |
| Q3 2021 | $289,836,000 | +32.9% | 4,349,279 | +6.1% | 3.30% | +38.4% |
| Q2 2021 | $218,159,000 | +31.6% | 4,100,739 | +7.3% | 2.38% | +24.4% |
| Q1 2021 | $165,825,000 | -16.5% | 3,821,739 | 0.0% | 1.92% | -10.8% |
| Q4 2020 | $198,501,000 | +58.9% | 3,821,739 | 0.0% | 2.15% | +29.3% |
| Q3 2020 | $124,933,000 | -31.9% | 3,821,739 | 0.0% | 1.66% | -42.0% |
| Q2 2020 | $183,520,000 | – | 3,821,739 | – | 2.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |